In another move to bolster its oncology portfolio, French pharma Servier has agreed to buy Agios Pharmaceuticals’ business, including its commercial, clinical and...
Eli Lilly is to buy Prevail Therapeutics, a US biotech focused on developing adeno-associated viral vector 9 (AAV9) gene therapies to treat neurodegenerative diseases, in...
The European Medicines Agency (EMA) on Dec. 21 provisionally cleared EU-wide use of the Pfizer-BioNTech Covid-19 vaccine, which will be marketed under the brand name...
The US Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for US biotech Moderna’s mRNA-based Covid-19 vaccine on Dec.18, a day after the...
Swedish CDMO Recipharm is investing in a capacity expansion at its facility located south of Tel Aviv in Israel, in order to support growing demand for cGMP clinical...
French family-owned CDMO Fareva has signed on to handle fill and finish manufacturing for German biotech CureVac’s mRNA-based Covid-19 vaccine candidate, CVnCoV, at the...
German biotech CureVac has started a Phase 2b/3 clinical trial of its Covid-19 vaccine candidate CVnCoV. Planned to enroll 36,500 participants in Europe and Latin America...
The US Food and Drug Administration on Dec. 11 awarded an emergency use authorization (EUA) for the Pfizer-BioNTech mRNA-based Covid-19 vaccine. The green light followed...
US pharma giant Merck has divested its direct holding in Moderna just as the US biotech is on the cusp of receiving an emergency use authorization (EUA) for its mRNA...
Bayer has taken another a step toward embracing cell therapy, this week signing a worldwide license agreement with Atara Biotherapeutics for next-generation, mesothelin...
